SHIRE 465 37.5 mg Pill - brown & white capsule/oblong, 19mm
Generic Name: amphetamine/dextroamphetamine
Pill with imprint SHIRE 465 37.5 mg is Brown & White, Capsule/Oblong and has been identified as Mydayis 37.5 mg. It is supplied by Shire US, Inc.
Mydayis is used in the treatment of ADHD and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Mydayis 37.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for SHIRE 465 37.5 mg
Mydayis
- Generic Name
- amphetamine/dextroamphetamine
- Imprint
- SHIRE 465 37.5 mg
- Strength
- 37.5 mg
- Color
- Brown & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Shire US, Inc.
- National Drug Code (NDC)
- 54092-0474
- Inactive Ingredients
-
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
sucrose,
magnesium silicate,
triethyl citrate,
ferric oxide red,
ferric oxide yellow,
titanium dioxide
Note: Inactive ingredients may vary.
More about Mydayis (amphetamine / dextroamphetamine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (142)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: CNS stimulants
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
